Amin, A., Plimack, E. R., Ernstoff, M. S., Lewis, L. D., Bauer, T. M., McDermott, D. F., Carducci, M., Kollmannsberger, C., Rini, B. I., Heng, D. Y. C., Knox, J., Voss, M. H., Spratlin, J., Berghorn, E., Yang, L., & Hammers, H. J. (2019). correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Journal for immunotherapy of cancer, 7(1), . http://access.bl.uk/ark:/81055/vdc_100135165105.0x000003